Serving leading biopharmaceutical companies globally:

Last Updated: February 27, 2020

DrugPatentWatch Database Preview

GAZYVA Drug Profile

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: GAZYVA

Patents:	26
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for GAZYVA

Recent Clinical Trials for GAZYVA

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Emory University	Phase 2
University of California, San Francisco	Phase 2
Fate Therapeutics	Phase 1

See all GAZYVA clinical trials

Pharmacology for GAZYVA

Mechanism of Action	CD20-directed Antibody Interactions

Patent Text Search: US Patents for GAZYVA

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	Start Trial	The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, DC) University of Virginia Patent Foundation (Charlottesville, VA)	2034-01-08	RX	Orphan	search
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	Start Trial	PRINCIPIA BIOPHARMA INC. (South San Francisco, CA)	2034-02-21	RX	Orphan	search
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	Start Trial	Celgene Corporation (Summit, NJ)	2035-12-02	RX	Orphan	search
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	Start Trial	Cipla Limited (Mumbai, IN)	2036-06-30	RX	Orphan	search
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	Start Trial	BEYONDBIO INC. (Daejeon, KR)	2035-02-04	RX	Orphan	search
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	Start Trial	UNIVERSITY OF UTAH RESEARCH FOUNDATION (Salt Lake City, GA)	2033-03-12	RX	Orphan	search
Genentech	GAZYVA	obinutuzumab	INJECTABLE;INJECTION	125486	001	2013-11-01	Start Trial	Calithera Biosciences, Inc. (South San Francisco, CA)	2035-10-05	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for GAZYVA

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Denmark	1194167	Start Trial
Japan	2001518930	Start Trial
Japan	5999217	Start Trial
Canada	2814962	Start Trial
Australia	2012250924	Start Trial
Japan	2010516675	Start Trial
South Korea	20100085932	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Boehringer Ingelheim

Dow

Medtronic

Moodys

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.